Steven Goldman, partner in the Toronto law firm of Goldman Hine LLP, former director Tribute Pharmaceuticals, merged and continued on as Aralez Pharmaceuticals (Nasdaq: ARLZ) on Feb. 6, 2016, current director in Comstock Metals and Select Sands.
** Join us in our 100% FREE chat room ** Unlike day-trading which is based solely on technical analysis, we identify Story Trades by combining headline news, fundamental analysis, technical analysis, & social sentiment to achieve superior returns.
Financial Engineer. Big on Biotech. Using technical analysis, I am able to consistently produce profitable trades & abnormal returns. Made 1,000%+ on FB, NFLX, and REGN options. My goal is to become the greatest investor and trader that ever lived.
E-mail us email@example.com for permission to join our Investing, Forecast, and Swing trading subscription group. Limited to only serious "partners". Have outperformed market over 5 to 1 over last 24 months using our methods.